EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Lipid‐Sensitive Spider Peptide Toxin Exhibits Selective Anti‐Leukemia Efficacy through Multimodal Mechanisms

Peng Zhang, Wu Luo, Zixin Zhang, Mingchong Lv, Longkang Sang, Yuhan Wen, Lingxiang Wang, Changhao Ding, Kun Wu, Fengjiao Li, Yueqi Nie, Jiaoyue Zhu und 5 weitere

Advanced Science · 2024-08 · 11 (32)

DOI: 10.1002/advs.202404937 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 04.07.2024. Verfasst von Peng Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hu…. Hauptthemen laut MEDLINE: Leukemia, Mice, Nude. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Subversive Innovation Competition Project of Hunan Province, Science and Technology Innovation Program of Hunan Province, Scientific Research Program of FuRong Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti‐cancer peptides (ACPs) represent a promising potential for cancer treatment, although their mechanisms need to be further elucidated to improve their application in cancer therapy. Lycosin‐I, a linear amphipathic peptide isolated from the venom of Lycosa singorensis , shows significant anticancer potential. Herein, it is found that Lycosin‐I, which can self‐assemble into a nanosphere structure, has a multimodal mechanism of action involving lipid binding for the selective and effective treatment of leukemia. Mechanistically, Lycosin‐I selectively binds to the K562 cell membrane, likely due to its preferential interaction with negatively charged phosphatidylserine, and rapidly triggers membrane lysis, particularly at high concentrations. In addition, Lycosin‐I induces apoptosis, cell cycle arrest in the G1 phase and ferroptosis in K562 cells by suppressing the PI3K‐AKT‐mTOR signaling pathway and activating cell autophagy at low concentrations. Furthermore, intraperitoneal injection of Lycosin‐I inhibits tumor growth of K562 cells in a nude mouse xenograft model without causing side effects. Collectively, the multimodal effect of Lycosin‐I can provide new insights into the mechanism of ACPs, and Lycosin‐I, which is characterized by high potency and specificity, can be a promising lead for the development of anti‐leukemia drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeukemiaMice, NudeAnimalsMiceHumansK562 CellsApoptosisSpider VenomsDisease Models, AnimalAntineoplastic AgentsSignal TransductionXenograft Model Antitumor AssaysCell Line, TumorPeptidesAntimicrobial Cationic Peptides

Stichwörter der Autor:innen

PI3K‐AKT‐mTOR signaling pathwayanticancer peptideapoptosiscell cycle arrestferroptosisleukemia

Substanzen

Spider Venomslycosin-I, Lycosa singorensisAntineoplastic AgentsPeptidesAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan, 410081, China.
  • Peptide and Small Molecule Drug R&D Platform, Furong Laboratory, Changsha, Hunan, 410081, China.
  • Institute of Interdisciplinary Studies, Hunan Normal University, Changsha, 410081, China.
  • College of Biology, Hunan University, Changsha, Hunan, 410082, China.
  • Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
  • Department of Hematology, The Third Affiliated Hospital of Southern Medical University, Southern Medical University, Guangzhou, 510630, China.

ORCID-Profile: Zhonghua Liu

Förderung

  • Subversive Innovation Competition Project of Hunan Province
  • Science and Technology Innovation Program of Hunan Province
  • Scientific Research Program of FuRong Laboratory
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, P., Luo, W., Zhang, Z., Lv, M., Sang, L., Wen, Y., Wang, L., Ding, C., Wu, K., Li, F., Nie, Y., Zhu, J., Liu, X., Yi, Y., Ding, X., Zeng, Y., & Liu, Z. (2024). A Lipid‐Sensitive Spider Peptide Toxin Exhibits Selective Anti‐Leukemia Efficacy through Multimodal Mechanisms. Advanced Science, 11(32). https://doi.org/10.1002/advs.202404937

Vancouver

Zhang P, Luo W, Zhang Z, Lv M, Sang L, Wen Y, et al. A Lipid‐Sensitive Spider Peptide Toxin Exhibits Selective Anti‐Leukemia Efficacy through Multimodal Mechanisms. Advanced Science. 2024;11(32). doi:10.1002/advs.202404937

BibTeX
@article{Zhang2024,
  author = {Zhang, Peng and Luo, Wu and Zhang, Zixin and Lv, Mingchong and Sang, Longkang and Wen, Yuhan and Wang, Lingxiang and Ding, Changhao and Wu, Kun and Li, Fengjiao and Nie, Yueqi and Zhu, Jiaoyue and Liu, Xiaofeng and Yi, Yan and Ding, Xiaofeng and Zeng, Youlin and Liu, Zhonghua},
  title = {A Lipid‐Sensitive Spider Peptide Toxin Exhibits Selective Anti‐Leukemia Efficacy through Multimodal Mechanisms},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {32},
  doi = {10.1002/advs.202404937}
}
Kostenlos starten →